1. Home
  2. NUS vs BDSX Comparison

NUS vs BDSX Comparison

Compare NUS & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nu Skin Enterprises Inc.

NUS

Nu Skin Enterprises Inc.

N/A

Current Price

$4.22

Market Cap

242.4M

Sector

Health Care

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$8.16

Market Cap

276.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NUS
BDSX
Founded
1984
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.4M
276.2M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
NUS
BDSX
Price
$4.22
$8.16
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $36.33
AVG Volume (30 Days)
★ 445.0K
145.2K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 5.85%
N/A
EPS Growth
★ 207.80
N/A
EPS
N/A
★ N/A
Revenue
★ $3,176,718,000.00
$88,499,000.00
Revenue This Year
N/A
$26.35
Revenue Next Year
$10.10
$20.40
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 48.98
24.08
52 Week Low
$4.10
$5.26
52 Week High
$11.67
$31.97

Technical Indicators

Market Signals
Indicator
NUS
BDSX
Relative Strength Index (RSI) 37.29 17.71
Support Level N/A N/A
Resistance Level $4.94 $16.66
Average True Range (ATR) 0.25 2.06
MACD -0.07 -1.39
Stochastic Oscillator 19.48 2.53

Price Performance

Historical Comparison
NUS
BDSX

About NUS Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: